CurrentCentenePolicy CP.MP.184

Home Ventilators

Medical necessity criteria for initial and continued use of noninvasive and invasive home ventilators for non‑Medicare Centene-affiliated plans; who qualifies and documentation/prior authorization expectations.

Policy Summary

PayerCentene

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeMaterial coverage and operational language updates (initial certification clarifiedRAD/CPAP exclusions revisedbackup ventilator criteria added).

Effective Date

Next Review Date

Key ActionObtain prior authorization for initial noninvasive ventilator use for a three-month period and document ongoing benefit and average use ≥4 hours/day for continued coverage.

SourceLink

POLICY UPDATE CHANGES

Clarified initial request is for three months for noninvasive home ventilator use.

Replaced BiPAP failure and contraindication criteria with requirement that member/enrollee could not be appropriately treated with a respiratory assist device (RAD) and that the device will not be used to provide RAD or CPAP therapy.

Added criteria for second/back-up ventilator (noninvasive or invasive) for specific clinical or logistical reasons (e.g., different purposes, wheelchair use, remote residence).

Added HCPCS code E0465 and included descriptions for E0465–E0468.

3 monthsinitial certification period

>=4 hrs/24hminimum average daily use

BMI >=30OHS BMI threshold

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Home Ventilators

Initial Therapy — Restrictive/Neuromuscular

Covered when ALL of the following are met for initial request (first 3 months):

I.A Initial criteria (restrictive thoracic/neuromuscular): 1) Documentation of neuromuscular disease (e.g., amyotrophic lateral sclerosis) or a severe thoracic cage abnormality (e.g., post‑thoracoplasty, severe kyphoscoliosis); AND 2) one of the following obtained while the member/enrollee was stable (not in acute respiratory failure): an awake arterial blood gas PaCO2 >= 45 mm Hg measured on room air or prescribed oxygen; OR sleep oximetry demonstrating O2 saturation <88% for at least five minutes while breathing prescribed O2; OR if neuromuscular disease is present, maximal inspiratory pressure <= 60 cm H2O or forced vital capacity <= 50% predicted; AND 3) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 4) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).PaCO2 >= 45 mm Hg; MIP <= 60 cm H2O; FVC <= 50% predicted; sleep SpO2 <88% >=5 minutes

Initial approval period is 3 months.

Initial Therapy — Severe COPD

Covered when ALL of the following are met for initial request (first 3 months):

I.B Initial criteria (severe COPD): 1) An awake arterial blood gas PaCO2 >= 52 mm Hg measured at baseline while breathing baseline and prescribed FiO2 as specified; AND 2) CPAP/apnea treatment has been considered and ruled out (formal sleep testing not required if the medical record demonstrates sleep apnea is not the predominant cause of awake hypercapnia or nocturnal desaturation); AND 3) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 4) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).PaCO2 >= 52 mm Hg

Initial approval period is 3 months.

Initial Therapy — Obesity Hypoventilation Syndrome

Covered when ALL of the following are met for initial request (first 3 months):

I.C Initial criteria (obesity hypoventilation syndrome): 1) BMI >= 30; AND 2) an awake arterial blood gas PaCO2 >= 45 mm Hg measured at baseline while breathing prescribed FiO2; AND 3) sleep‑disordered hypoventilation documented by polysomnography and other conditions are not the primary cause of hypoventilation; AND 4) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 5) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).BMI >= 30; PaCO2 >= 45 mm Hg

Initial approval period is 3 months. Polysomnography required to document hypoventilation.

Continuation Therapy

Covered when ALL of the following are met for continued use after initial three-month certification:

II Continued use (noninvasive): 1) Documentation supports ongoing benefits from use of the device; AND 2) average use at least 4 hours per 24‑hour period; AND 3) the noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).>= 4 hours per 24-hour period

Medical director review required for overlap syndromes (e.g., COPD plus sleep apnea).

Invasive Ventilator Criteria

Covered when ALL of the following are met:

IV Invasive ventilator (initial and ongoing): Initial and ongoing use of an invasive ventilator is medically necessary for long‑term or chronic conditions or diseases affecting the ability to effectively maintain adequate respiratory status (examples: neuromuscular disease, thoracic restrictive disease, chronic respiratory failure following COPD), or when airway protection is required or noninvasive ventilation is contraindicated.

Applies to non‑Medicare Centene‑affiliated plans; see corresponding Medicare policy for Medicare members.

Backup Ventilator Coverage

A second or back-up noninvasive or invasive ventilator is considered medically necessary for ANY of the following:

V Second/back-up ventilator: A) A second ventilator serves a different purpose from the first based on medical needs (e.g., two different ventilator types required for different indications); OR B) the member/enrollee is confined to a wheelchair and requires a wheelchair‑mounted ventilator during the day and another ventilator for use while in bed; OR C) residence in remote areas with poor emergency access;

Supportive documentation required to justify medical necessity for a second/back‑up ventilator.

Use of a home ventilator solely to provide respiratory assist device (RAD) or CPAP therapy is excluded under the noninvasive ventilator coverage criteria. The device must be intended to provide ventilatory support (for example, average volume assured pressure support) and the documentation must explicitly state that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy.

Language authorizing ventilator coverage based on prior constructs such as ‘‘BiPAP failure’’ or other BiPAP treatment‑failure formulations has been removed. Requests must now document that the member/enrollee could not be appropriately treated with a respiratory assist device (RAD), and that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy. BiPAP failure is no longer a standalone medical‑necessity criterion.

Coding and Utilization Metrics

Covered HCPCS codes referencedHCPCS

E0465	Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube).
E0466	Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell).
E0467	Home ventilator, multi-function respiratory device, also performs functions of oxygen concentration, nebulization, aspiration, and cough stimulation; includes accessories.
E0468	Home ventilator; dual-function respiratory device, also performs additional function of cough stimulation; includes accessories.

Average daily use — continued coverage

Minimum average daily use>= 4 hours per 24-hour period

BMI for Obesity Hypoventilation Syndrome (OHS)

BMI threshold for OHS>= 30

Arterial blood gas (PaCO2) thresholds

PaCO2 threshold (general indications)>= 45 mm Hg

PaCO2 threshold (severe COPD initial criteria)>= 52 mm Hg

Provider Requirements and Prior Authorization

Prior Authorization

Prior Authorization Required — Timeframe & Continued-Use

Prior authorization is required for initial requests and is issued for the first three months of noninvasive home ventilator (NIV) use. Continued authorization beyond the initial three-month period requires documentation demonstrating ongoing benefit and continued medical necessity.

Initial authorization period: 3 months
Continuation requires documentation of ongoing benefit and at-home use (see documentation callout)

Documentation Required

Required Clinical Documentation

Submit clinical documentation with every prior authorization request. For initial requests include: diagnosis (e.g., neuromuscular disease, severe thoracic cage abnormality, obesity hypoventilation syndrome, severe COPD), relevant objective testing performed while the member was stable (not in acute respiratory failure), and evidence that a respiratory assist device (RAD) or CPAP would not appropriately treat the member when applicable.

Clinical Background

Respiratory failure may reflect impaired ventilatory (CO2 retention) or oxygenation (hypoxemia) function and can be acute or chronic. Noninvasive ventilation (NIV) delivers positive pressure via noninvasive interfaces (masks, nasal pillows, etc.) to support ventilation in selected acute and chronic respiratory failures and in the home setting can improve symptoms, quality of life, and reduce readmission and mortality. In contrast, invasive ventilation uses an invasive airway (eg, tracheostomy) when airway protection or ventilatory requirements exceed what can be provided noninvasively. The policy requires objective documentation of respiratory impairment (examples include awake PaCO2 ≥ 45 mm Hg for some indications, sleep oximetry with SpO2 <88% for ≥5 minutes, or physiologic measures such as maximal inspiratory pressure or FVC for neuromuscular disease) to support use of a home ventilator.

Definitions

Noninvasive ventilation (NIV) — definition and interfaces

DefinitionAdministration of positive pressure to the lungs via noninvasive interfaces such as masks, nasal pillows, or helmets.

Common interfacesOronasal mask, nasal mask, nasal prongs, full-face mask, mouthpieces, nasal pillows, helmets.

Invasive ventilation — definition and invasive interfaces

DefinitionAdministration of positive pressure to the lungs through an invasive interface such as a tracheostomy tube or endotracheal tube.

Common invasive interfacesTracheostomy tube, endotracheal tube.